PL61953B1 - - Google Patents
Download PDFInfo
- Publication number
- PL61953B1 PL61953B1 PL126272A PL12627268A PL61953B1 PL 61953 B1 PL61953 B1 PL 61953B1 PL 126272 A PL126272 A PL 126272A PL 12627268 A PL12627268 A PL 12627268A PL 61953 B1 PL61953 B1 PL 61953B1
- Authority
- PL
- Poland
- Prior art keywords
- solution
- plasminogen
- zinc salt
- zinc
- aqueous
- Prior art date
Links
- 239000000243 solution Substances 0.000 claims description 23
- 102000013566 Plasminogen Human genes 0.000 claims description 19
- 108010051456 Plasminogen Proteins 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 15
- 150000003751 zinc Chemical class 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 5
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 4
- 229940037001 sodium edetate Drugs 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 238000004440 column chromatography Methods 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- -1 sulfate or acetate Chemical class 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000007975 buffered saline Substances 0.000 description 2
- 229940009662 edetate Drugs 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000000963 caseinolytic effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000021962 pH elevation Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL61953B1 true PL61953B1 (enExample) | 1970-12-30 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Seegers et al. | Some properties of purified prothrombin and its activation with sodium citrate | |
| EP0244834B1 (de) | Verfahren zur Herstellung eines Faktor V-Konzentrats | |
| Weiss | A study of the cation-and pH-dependent stability of factors V and VIII in plasma | |
| US4297344A (en) | Blood coagulation factors and process for their manufacture | |
| US3931399A (en) | Process for isolating a fibrin-stabilizing factor | |
| US4083961A (en) | Plasminogen activator pharmaceutical compositions | |
| EP0041173B2 (en) | Blood-coagulation-promoting products and methods of preparing them | |
| PL99599B1 (pl) | Sposob otrzymywania tolerowanej srodzylnie gammaglobuliny | |
| Stefanini | Basic mechanisms of hemostasis | |
| Beeby et al. | The action of rennin on casein The disruption of the k-casein complex | |
| SE452250B (sv) | Sett att framstella ett koncentrat av protrombinkomplex | |
| Banks et al. | Studies on mustard gas (ββ′-dichlorodiethyl sulphide) and some related compounds: 4. Their action on proteins (studied with the aid of radioactive sulphur) | |
| PL61953B1 (enExample) | ||
| Ferguson | An intermediary calcium complex in blood coagulation | |
| Held et al. | Binding of calcium by human plasma proteins under simulated physiologic conditions | |
| US2770616A (en) | Fractionation of proteinaceous materials in blood plasma and liver tissue | |
| US2923665A (en) | Processes for preparing human plasminogen from human placenta sources | |
| Gotterer et al. | Some factors which influence vesiculase action | |
| US3318771A (en) | Process for the recovery of plasminogen from animal blood serum or animal blood plasma, preferably from pig's blood | |
| Smith et al. | Lung extract and blood clotting | |
| US2922745A (en) | Purification of profibrinolysin | |
| DE69222947T2 (de) | Reinigung von faktor xiii | |
| US2847348A (en) | Plasma fractionation and product therefrom | |
| Jackson | Purification of staphylococcal-alpha-lysin | |
| US3332852A (en) | Process for the recovery of plasminogen from blood serum or blood plasma |